C20-5HT and C22-5HT were isolated from CSE as the major compounds contributing to the MSTN inhibition, suggesting the potential of CSE, C20-5HT, and C22-5HT being developed as agents to combat muscle atrophy and metabolic syndrome. The gene discussed is MSTN; the disease is muscle atrophy.